IPF

Pliant Brings in Outside Experts to Review IPF Study Pause
BioSpace
Fri, 02/14/25 - 09:36 am
Pliant Therapeutics
IPF
clinical trials
bexotegrast
Ten years on, Roche jettisons InterMune and Esbriet in US
Pharmaphorum
Tue, 02/11/25 - 11:08 am
Roche
InterMune
Esbriet
IPF
M&A
Boehringer widens fibrosis drug’s approval path after boosting lung function in 2nd phase 3 trial
Fierce Biotech
Mon, 02/10/25 - 11:52 am
Boehinger Ingelheim
IPF
clinical trials
nerandomilast
Pliant slumps on decision to pause lung disease drug trial
Pharmaphorum
Mon, 02/10/25 - 10:09 am
Pliant Therapeutics
clinical trials
IPF
bexotegrast
Eli Lilly pushes into pulmonary fibrosis with $99M deal for Mediar's midphase prospect
Fierce Biotech
Fri, 01/10/25 - 11:39 am
Eli Lilly
idiopathic pulmonary fibrosis
IPF
Mediar Therapeutics
PureTech's lung fibrosis drug slows decline in phase 2 trial
Fierce Biotech
Mon, 12/16/24 - 11:32 am
PureTech
IPF
deupirfenidone
clinical trials
Novartis terminating midphase SMURF1 trial
Fierce Biotech
Mon, 10/14/24 - 10:19 am
Novartis
clinical trials
IPF
LTP001
Boehringer's phase 3 lung fibrosis trial hits primary endpoint, teeing up filings for Ofev successor
Fierce Biotech
Mon, 09/16/24 - 10:57 am
Boehringer Ingelheim
IPF
clinical trials
nerandomilast
Taking on pharma giants, Endeavor links IPF drug to improved lung function in phase 2
Fierce Biotech
Mon, 05/20/24 - 11:21 am
Endeavor BioMedicines
hedgehog pathway inhibitor
IPF
clinical trials
Pliant Therapeutics' Drug Trial Shows Promise In Reversing Lung Fibrosis In Patients
Benzinga
Tue, 05/14/24 - 11:44 am
Pliant Therapeutics
clinical trials
bexotegrast
IPF
Endeavor pulls in $132M to back cancer, lung disease drugs
BioPharma Dive
Wed, 04/24/24 - 08:45 am
Endeavor BioMedicines
funding
IPF
Eli Lilly
Neuro and inflammation biotech Contineum Therapeutics sets terms for $150 million IPO
Renaissance Capital
Mon, 04/1/24 - 12:25 pm
IPOs
Contineum Therapeutics
IPF
multiple sclerosis
Brainomix AI shows its worth in AZ pulmonary fibrosis trial
Pharmaphorum
Wed, 03/27/24 - 10:55 am
AstraZeneca
Brainomix
tralokinumab
IPF
artificial intelligence
Roche Reassesses Esbriet's Future Amidst Generic Drug Competition
Medriva
Tue, 02/27/24 - 11:28 am
Roche
generics
Esbriet
IPF
FibroGen plans new round of cost cuts after latest study setback
BioPharma Dive
Mon, 06/26/23 - 08:41 pm
FibroGen
IPF
pamvrelumab
clinical trials
First Human Trials Begin for AI-Designed Drug
The Daily Upside
Mon, 06/26/23 - 08:39 pm
Insilico
clinical trials
artificial intelligence
INS018_055
IPF
Late-stage pipeline for idiopathic pulmonary fibrosis is small but growing
Clinical Trials Arena
Mon, 06/19/23 - 11:39 am
IPF
Roche
Esbriet
Pirespa
Boehringer Ingelheim
Ofev
Bridge doses first patient in Phase lla trial of IPF therapy
Clinical Trials Arena
Thu, 04/13/23 - 11:55 am
Bridge Biotherapeutics
clinical trials
BBT-877
IPF
Promising IPF treatment results sent Pliant Therapeutics stock soaring
Investors Business Daily
Tue, 01/24/23 - 10:28 am
Pliant Therapeutics
clinical trials
IPF
bexotegrast
Digital therapeutic cuts IPF-related anxiety by half in pilot study
Pharmaphorum
Thu, 10/13/22 - 09:32 am
Alex Therapeutics
Medtech
digital therapeutics
anxiety
IPF

Pages